Quantitative Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.42M | Buy |
13,499
+10,485
| +348% | +$7.14M | 0.92% | 22 |
|
|
2026
Q1 | $2.33M | Buy |
+3,014
| New | +$2.31M | 0.24% | 118 |
|
|
2025
Q3 | – | Sell |
-678
| Closed | -$355K | – | 462 |
|
|
2025
Q2 | $355K | Buy |
+678
| New | +$378K | 0.05% | 236 |
|
|
2025
Q1 | – | Sell |
-6,898
| Closed | -$4.91M | – | 457 |
|
|
2024
Q4 | $4.91M | Buy |
6,898
+1,686
| +32% | +$1.41M | 0.37% | 66 |
|
|
2024
Q3 | $5.48M | Buy |
5,212
+660
| +14% | +$734K | 0.54% | 38 |
|
|
2024
Q2 | $4.78M | Sell |
4,552
-3,091
| -40% | -$3M | 0.52% | 44 |
|
|
2024
Q1 | $7.36M | Sell |
7,643
-17,552
| -70% | -$16.7M | 0.43% | 45 |
|
|
2023
Q4 | $22.1M | Buy |
25,195
+22,087
| +711% | +$18.2M | 1.27% | 14 |
|
|
2023
Q3 | $2.56M | Buy |
+3,108
| New | +$2.44M | 0.39% | 59 |
|
|
2023
Q2 | – | Sell |
-14,556
| Closed | -$12M | – | 347 |
|
|
2023
Q1 | $12M | Buy |
+14,556
| New | +$11M | 2.52% | 7 |
|
|
2022
Q2 | – | Sell |
-23,747
| Closed | -$16.6M | – | 293 |
|
|
2022
Q1 | $16.6M | Buy |
23,747
+16,540
| +229% | +$10.5M | 1.79% | 7 |
|
|
2021
Q4 | $4.55M | Sell |
7,207
-7,980
| -53% | -$4.91M | 0.64% | 42 |
|
|
2021
Q3 | $9.19M | Buy |
15,187
+11,175
| +279% | +$6.94M | 0.83% | 27 |
|
|
2021
Q2 | $2.24M | Buy |
+4,012
| New | +$2.03M | 0.2% | 117 |
|
|
2020
Q1 | – | Sell |
-17,572
| Closed | -$6.6M | – | 769 |
|
|
2019
Q4 | $6.6M | Buy |
+17,572
| New | +$5.91M | 0.2% | 129 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$205K | – | 794 |
|
|
2019
Q1 | $205K | Sell |
500
-2,200
| -81% | -$906K | 0.01% | 602 |
|
|
2018
Q4 | $1.01M | Buy |
2,700
+200
| +8% | +$73.2K | 0.05% | 284 |
|
|
2018
Q3 | $1.01M | Buy |
+2,500
| New | +$951K | 0.04% | 300 |
|
|
2017
Q3 | – | Sell |
-91,600
| Closed | -$45M | – | 812 |
|
|
2017
Q2 | $45M | Buy |
+91,600
| New | +$40.1M | 0.68% | 18 |
|
|
2016
Q2 | – | Sell |
-3,500
| Closed | -$1.26M | – | 891 |
|
|
2016
Q1 | $1.26M | Buy |
+3,500
| New | +$1.44M | 0.06% | 357 |
|
|
2015
Q2 | – | Sell |
-5,900
| Closed | -$2.66M | – | 647 |
|
|
2015
Q1 | $2.66M | Buy |
5,900
+2,200
| +59% | +$932K | 0.26% | 76 |
|
|
2014
Q4 | $1.52M | Buy |
+3,700
| New | +$1.46M | 0.23% | 95 |
|
|
2013
Q4 | – | Sell |
-9,200
| Closed | -$2.88M | – | 693 |
|
|
2013
Q3 | $2.88M | Buy |
+9,200
| New | +$2.42M | 0.26% | 76 |
|
Other funds holding REGN
Quantitative Investment Management's REGN Position: Q2 2026 in Review
Quantitative Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 348% in Q2 2026, buying an estimated $7.14M and bringing the position to 13,499 shares worth $8.42M. The position accounts for 0.92% of the portfolio, ranked #22.
Quantitative Investment Management first reported a position in REGN in Q3 2013 and has held it in 23 quarters since. The position peaked at $45M in Q2 2017. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Quantitative Investment Management held 13,499 shares of Regeneron Pharmaceuticals worth $8.42M as of Q2 2026.
- Quantitative Investment Management bought 10,485 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $7.14M.
- Regeneron Pharmaceuticals made up 0.92% of Quantitative Investment Management's portfolio in Q2 2026, its #22 holding.
- Quantitative Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 23 quarters since.
- Quantitative Investment Management's Regeneron Pharmaceuticals position peaked at $45M in Q2 2017.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.